Normal Lung Function and Mortality in World Trade Center Responders and National Health and Nutrition Examination Survey III Participants
-
2024/05/15
Details
-
Personal Author:
-
Description:Rationale: Low FEV1 is a biomarker of increased mortality. The association of normal lung function and mortality is not well described. Objectives: To evaluate the FEV1-mortality association among participants with normal lung function. Methods: A total of 10,999 Fire Department of the City of New York (FDNY) responders and 10,901 Third National Health and Nutrition Examination Survey (NHANES III) participants, aged 18-65 years with FEV1 ≥80% predicted, were analyzed, with FEV1 percent predicted calculated using Global Lung Function Initiative Global race-neutral reference equations. Mortality data were obtained from linkages to the National Death Index. Cox proportional hazards models estimated the association between FEV1 and all-cause mortality, controlling for age, sex, race/ethnicity, smoking history, and, for FDNY, work assignment. Cohorts were followed for a maximum of 20.3 years. Measurements and Main Results: We observed 504 deaths (4.6%) of 10,999 for FDNY and 1,237 deaths (9.4% [weighted]) of 10,901 for NHANES III. Relative to FEV1 ≥120% predicted, mortality was significantly higher for FEV1 100-109%, 90-99%, and 80-89% predicted in the FDNY cohort. In the NHANES III cohort, mortality was significantly higher for FEV1 90-99% and 80-89% predicted. Each 10% higher predicted FEV1 was associated with 15% (hazard ratio, 0.85; 95% confidence interval, 0.80-0.91) and 23% (hazard ratio, 0.77; 95% confidence interval, 0.71-0.84) lower mortality for FDNY and NHANES III, respectively. Conclusions: In both cohorts, higher FEV1 is associated with lower mortality, suggesting higher FEV1 is a biomarker of better health. These findings demonstrate that a single cross-sectional measurement of FEV1 is predictive of mortality over two decades, even when FEV1 is in the normal range. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1073-449X
-
Document Type:
-
Funding:
-
Genre:
-
Place as Subject:
-
CIO:
-
Topic:
-
Location:
-
Volume:209
-
Issue:10
-
NIOSHTIC Number:nn:20069721
-
Citation:Am J Respir Crit Care Med 2024 May; 209(10):1229-1237
-
Contact Point Address:Michael D. Weiden, M.D., M.S., Bureau of Health Services, 9 Metrotech Center, Brooklyn, NY 11201
-
Email:michael.weiden@nyulangone.org
-
Federal Fiscal Year:2024
-
Performing Organization:New York University School of Medicine
-
Peer Reviewed:True
-
Start Date:20190701
-
Source Full Name:American Journal of Respiratory and Critical Care Medicine
-
End Date:20210630
-
Collection(s):
-
Main Document Checksum:urn:sha-512:a679c2bdd1e6d4bc8ce0cf4d5ab8fa8d60786a0a37e6d6db412b45ac65bd37290dfe00d852929fbefbbcc64f270eb0b1c1635887aaee974d2e3d5e20dd5ad8e9
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like